Global Insulin Glargine Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application

Publisher Name :
Date: 27-Aug-2022
No. of pages: 97
Inquire Before Buying

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Market Analysis and Insights: Global Insulin Glargine Market

Due to the COVID-19 pandemic, the global Insulin Glargine market size is estimated to be worth US$ 6461 million in 2021 and is forecast to a readjusted size of US$ 8487.8 million by 2028 with a CAGR of 4.0% during the review period.

Global Insulin Glargine key players include Sanofi, Eli Lilly, etc. Global top two manufacturers hold a share nearly 50%.

USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.

In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.

Global Insulin Glargine Scope and Market Size

The global Insulin Glargine market is segmented by region (country), company, by Type and by Application. Players, stakeholders, and other participants in the global Insulin Glargine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

Segment by Type

- Prefilled Injection

- Non-Prefilled Injection

Segment by Application

- Type 1 Diabetes Treatment

- Type 2 Diabetes Treatment

By Company

- Sanofi

- Eli Lilly

- Viatris

- Gan&Lee Pharmaceuticals

- Tonghua Dongbao Pharmaceutical

- United Laboratories International

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Insulin Glargine Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application

Table of Contents
1 Insulin Glargine Market Overview
1.1 Insulin Glargine Product Overview
1.2 Insulin Glargine Market Segment by Type
1.2.1 Prefilled Injection
1.2.2 Non-Prefilled Injection
1.3 Global Insulin Glargine Market Size by Type
1.3.1 Global Insulin Glargine Market Size Overview by Type (2017-2028)
1.3.2 Global Insulin Glargine Historic Market Size Review by Type (2017-2022)
1.3.2.1 Global Insulin Glargine Sales Breakdown in Volume by Type (2017-2022)
1.3.2.2 Global Insulin Glargine Sales Breakdown in Value by Type (2017-2022)
1.3.2.3 Global Insulin Glargine Average Selling Price (ASP) by Type (2017-2022)
1.3.3 Global Insulin Glargine Forecasted Market Size by Type (2023-2028)
1.3.3.1 Global Insulin Glargine Sales Breakdown in Volume by Type (2023-2028)
1.3.3.2 Global Insulin Glargine Sales Breakdown in Value by Type (2023-2028)
1.3.3.3 Global Insulin Glargine Average Selling Price (ASP) by Type (2023-2028)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Glargine Sales Breakdown by Type (2017-2022)
1.4.2 Europe Insulin Glargine Sales Breakdown by Type (2017-2022)
1.4.3 Asia-Pacific Insulin Glargine Sales Breakdown by Type (2017-2022)
1.4.4 Latin America Insulin Glargine Sales Breakdown by Type (2017-2022)
1.4.5 Middle East and Africa Insulin Glargine Sales Breakdown by Type (2017-2022)
2 Global Insulin Glargine Market Competition by Company
2.1 Global Top Players by Insulin Glargine Sales (2017-2022)
2.2 Global Top Players by Insulin Glargine Revenue (2017-2022)
2.3 Global Top Players Insulin Glargine Price (2017-2022)
2.4 Global Top Manufacturers Insulin Glargine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Glargine Market Competitive Situation and Trends
2.5.1 Insulin Glargine Market Concentration Rate (2017-2022)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Glargine Sales and Revenue in 2021
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Glargine as of 2021)
2.7 Date of Key Manufacturers Enter into Insulin Glargine Market
2.8 Key Manufacturers Insulin Glargine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Glargine Status and Outlook by Region
3.1 Global Insulin Glargine Market Size and CAGR by Region: 2017 VS 2021 VS 2028
3.2 Global Insulin Glargine Historic Market Size by Region
3.2.1 Global Insulin Glargine Sales in Volume by Region (2017-2022)
3.2.2 Global Insulin Glargine Sales in Value by Region (2017-2022)
3.2.3 Global Insulin Glargine Sales (Volume & Value) Price and Gross Margin (2017-2022)
3.3 Global Insulin Glargine Forecasted Market Size by Region
3.3.1 Global Insulin Glargine Sales in Volume by Region (2023-2028)
3.3.2 Global Insulin Glargine Sales in Value by Region (2023-2028)
3.3.3 Global Insulin Glargine Sales (Volume & Value), Price and Gross Margin (2023-2028)
4 Global Insulin Glargine by Application
4.1 Insulin Glargine Market Segment by Application
4.1.1 Type 1 Diabetes Treatment
4.1.2 Type 2 Diabetes Treatment
4.2 Global Insulin Glargine Market Size by Application
4.2.1 Global Insulin Glargine Market Size Overview by Application (2017-2028)
4.2.2 Global Insulin Glargine Historic Market Size Review by Application (2017-2022)
4.2.2.1 Global Insulin Glargine Sales Breakdown in Volume, by Application (2017-2022)
4.2.2.2 Global Insulin Glargine Sales Breakdown in Value, by Application (2017-2022)
4.2.2.3 Global Insulin Glargine Average Selling Price (ASP) by Application (2017-2022)
4.2.3 Global Insulin Glargine Forecasted Market Size by Application (2023-2028)
4.2.3.1 Global Insulin Glargine Sales Breakdown in Volume, by Application (2023-2028)
4.2.3.2 Global Insulin Glargine Sales Breakdown in Value, by Application (2023-2028)
4.2.3.3 Global Insulin Glargine Average Selling Price (ASP) by Application (2023-2028)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Glargine Sales Breakdown by Application (2017-2022)
4.3.2 Europe Insulin Glargine Sales Breakdown by Application (2017-2022)
4.3.3 Asia-Pacific Insulin Glargine Sales Breakdown by Application (2017-2022)
4.3.4 Latin America Insulin Glargine Sales Breakdown by Application (2017-2022)
4.3.5 Middle East and Africa Insulin Glargine Sales Breakdown by Application (2017-2022)
5 North America Insulin Glargine by Country
5.1 North America Insulin Glargine Historic Market Size by Country
5.1.1 North America Insulin Glargine Sales in Volume by Country (2017-2022)
5.1.2 North America Insulin Glargine Sales in Value by Country (2017-2022)
5.2 North America Insulin Glargine Forecasted Market Size by Country
5.2.1 North America Insulin Glargine Sales in Volume by Country (2023-2028)
5.2.2 North America Insulin Glargine Sales in Value by Country (2023-2028)
6 Europe Insulin Glargine by Country
6.1 Europe Insulin Glargine Historic Market Size by Country
6.1.1 Europe Insulin Glargine Sales in Volume by Country (2017-2022)
6.1.2 Europe Insulin Glargine Sales in Value by Country (2017-2022)
6.2 Europe Insulin Glargine Forecasted Market Size by Country
6.2.1 Europe Insulin Glargine Sales in Volume by Country (2023-2028)
6.2.2 Europe Insulin Glargine Sales in Value by Country (2023-2028)
7 Asia-Pacific Insulin Glargine by Region
7.1 Asia-Pacific Insulin Glargine Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Glargine Sales in Volume by Region (2017-2022)
7.1.2 Asia-Pacific Insulin Glargine Sales in Value by Region (2017-2022)
7.2 Asia-Pacific Insulin Glargine Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Glargine Sales in Volume by Region (2023-2028)
7.2.2 Asia-Pacific Insulin Glargine Sales in Value by Region (2023-2028)
8 Latin America Insulin Glargine by Country
8.1 Latin America Insulin Glargine Historic Market Size by Country
8.1.1 Latin America Insulin Glargine Sales in Volume by Country (2017-2022)
8.1.2 Latin America Insulin Glargine Sales in Value by Country (2017-2022)
8.2 Latin America Insulin Glargine Forecasted Market Size by Country
8.2.1 Latin America Insulin Glargine Sales in Volume by Country (2023-2028)
8.2.2 Latin America Insulin Glargine Sales in Value by Country (2023-2028)
9 Middle East and Africa Insulin Glargine by Country
9.1 Middle East and Africa Insulin Glargine Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Glargine Sales in Volume by Country (2017-2022)
9.1.2 Middle East and Africa Insulin Glargine Sales in Value by Country (2017-2022)
9.2 Middle East and Africa Insulin Glargine Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Glargine Sales in Volume by Country (2023-2028)
9.2.2 Middle East and Africa Insulin Glargine Sales in Value by Country (2023-2028)
10 Company Profiles and Key Figures in Insulin Glargine Business
10.1 Sanofi
10.1.1 Sanofi Corporation Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
10.1.4 Sanofi Insulin Glargine Products Offered
10.1.5 Sanofi Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Corporation Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
10.2.4 Eli Lilly Insulin Glargine Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Viatris
10.3.1 Viatris Corporation Information
10.3.2 Viatris Introduction and Business Overview
10.3.3 Viatris Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
10.3.4 Viatris Insulin Glargine Products Offered
10.3.5 Viatris Recent Development
10.4 Gan&Lee Pharmaceuticals
10.4.1 Gan&Lee Pharmaceuticals Corporation Information
10.4.2 Gan&Lee Pharmaceuticals Introduction and Business Overview
10.4.3 Gan&Lee Pharmaceuticals Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
10.4.4 Gan&Lee Pharmaceuticals Insulin Glargine Products Offered
10.4.5 Gan&Lee Pharmaceuticals Recent Development
10.5 Tonghua Dongbao Pharmaceutical
10.5.1 Tonghua Dongbao Pharmaceutical Corporation Information
10.5.2 Tonghua Dongbao Pharmaceutical Introduction and Business Overview
10.5.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
10.5.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Products Offered
10.5.5 Tonghua Dongbao Pharmaceutical Recent Development
10.6 United Laboratories International
10.6.1 United Laboratories International Corporation Information
10.6.2 United Laboratories International Introduction and Business Overview
10.6.3 United Laboratories International Insulin Glargine Sales, Revenue and Gross Margin (2017-2022)
10.6.4 United Laboratories International Insulin Glargine Products Offered
10.6.5 United Laboratories International Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Glargine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Glargine Industrial Chain Analysis
11.4 Insulin Glargine Market Dynamics
11.4.1 Insulin Glargine Industry Trends
11.4.2 Insulin Glargine Market Drivers
11.4.3 Insulin Glargine Market Challenges
11.4.4 Insulin Glargine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Glargine Distributors
12.3 Insulin Glargine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Prefilled Injection
Table 2. Major Company of Non-Prefilled Injection
Table 3. Global Insulin Glargine Sales by Type 2017 VS 2021 VS 2028 (US$ Million)
Table 4. Global Insulin Glargine Sales by Type (2017-2022) & (M mL)
Table 5. Global Insulin Glargine Sales Market Share in Volume by Type (2017-2022)
Table 6. Global Insulin Glargine Sales by Type (2017-2022) & (US& Million)
Table 7. Global Insulin Glargine Market Share in Value by Type (2017-2022)
Table 8. Global Insulin Glargine Price by Type (2017-2022) & (USD/mL)
Table 9. Global Insulin Glargine Sales by Type (2023-2028) & (M mL)
Table 10. Global Insulin Glargine Sales Market Share in Volume by Type (2023-2028)
Table 11. Global Insulin Glargine Sales by Type (2023-2028) & (US$ Million)
Table 12. Global Insulin Glargine Sales Market Share in Value by Type (2023-2028)
Table 13. Global Insulin Glargine Price by Type (2023-2028) & (USD/mL)
Table 14. North America Insulin Glargine Sales by Type (2017-2022) & (M mL)
Table 15. North America Insulin Glargine Sales by Type (2017-2022) & (US$ Million)
Table 16. Europe Insulin Glargine Sales (M mL) by Type (2017-2022)
Table 17. Europe Insulin Glargine Sales by Type (2017-2022) & (US$ Million)
Table 18. Asia-Pacific Insulin Glargine Sales (M mL) by Type (2017-2022)
Table 19. Asia-Pacific Insulin Glargine Sales by Type (2017-2022) & (US$ Million)
Table 20. Latin America Insulin Glargine Sales (M mL) by Type (2017-2022)
Table 21. Latin America Insulin Glargine Sales by Type (2017-2022) & (US$ Million)
Table 22. Middle East and Africa Insulin Glargine Sales (M mL) by Type (2017-2022)
Table 23. Middle East and Africa Insulin Glargine Sales by Type (2017-2022) & (US$ Million)
Table 24. Global Insulin Glargine Sales by Company (2017-2022) & (M mL)
Table 25. Global Insulin Glargine Sales Share by Company (2017-2022)
Table 26. Global Insulin Glargine Revenue by Company (2017-2022) & (US$ Million)
Table 27. Global Insulin Glargine Revenue Share by Company (2017-2022)
Table 28. Global Market Insulin Glargine Price by Company (2017-2022) & (USD/mL)
Table 29. Global Insulin Glargine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Insulin Glargine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Glargine as of 2021)
Table 32. Date of Key Manufacturers Enter into Insulin Glargine Market
Table 33. Key Manufacturers Insulin Glargine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Insulin Glargine Market Size Comparison by Region (US$ Million): 2017 VS 2021 VS 2028
Table 36. Global Insulin Glargine Sales by Region (2017-2022) & (M mL)
Table 37. Global Insulin Glargine Sales Market Share in Volume by Region (2017-2022)
Table 38. Global Insulin Glargine Sales by Region (2017-2022) & (US$ Million)
Table 39. Global Insulin Glargine Sales Market Share in Value by Region (2017-2022)
Table 40. Global Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
Table 41. Global Insulin Glargine Sales by Region (2023-2028) & (M mL)
Table 42. Global Insulin Glargine Sales Market Share in Volume by Region (2023-2028)
Table 43. Global Insulin Glargine Sales by Region (2023-2028) & (US$ Million)
Table 44. Global Insulin Glargine Sales Market Share in Value by Region (2023-2028)
Table 45. Global Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2023-2028)
Table 46. Global Insulin Glargine Sales by Application: 2017 VS 2021 VS 2028 (US$ Million)
Table 47. Global Insulin Glargine Sales by Application (2017-2022) & (M mL)
Table 48. Global Insulin Glargine Sales Market Share in Volume by Application (2017-2022)
Table 49. Global Insulin Glargine Sales by Application (2017-2022) & (US$ Million)
Table 50. Global Insulin Glargine Sales Market Share in Value by Application (2017-2022)
Table 51. Global Insulin Glargine Price by Application (2017-2022) & (USD/mL)
Table 52. Global Insulin Glargine Sales by Application (2023-2028) & (M mL)
Table 53. Global Insulin Glargine Sales Market Share in Volume by Application (2023-2028)
Table 54. Global Insulin Glargine Sales by Application (2023-2028) & (US$ Million)
Table 55. Global Insulin Glargine Sales Market Share in Value by Application (2023-2028)
Table 56. Global Insulin Glargine Price by Application (2023-2028) & (USD/mL)
Table 57. North America Insulin Glargine Sales by Application (2017-2022) (M mL)
Table 58. North America Insulin Glargine Sales by Application (2017-2022) & (US$ Million)
Table 59. North America Insulin Glargine Sales Market Share in Value by Application in 2021
Table 60. Europe Insulin Glargine Sales by Application (2017-2022) (M mL)
Table 61. Europe Insulin Glargine Sales by Application (2017-2022) & (US$ Million)
Table 62. Europe Insulin Glargine Sales Market Share in Value by Application in 2021
Table 63. Asia-Pacific Insulin Glargine Sales by Application (2017-2022) (M mL)
Table 64. Asia-Pacific Insulin Glargine Sales by Application (2017-2022) & (US$ Million)
Table 65. Asia-Pacific Insulin Glargine Sales Market Share in Value by Application in 2021
Table 66. Latin America Insulin Glargine Sales by Application (2017-2022) (M mL)
Table 67. Latin America Insulin Glargine Sales by Application (2017-2022) & (US$ Million)
Table 68. Latin America Insulin Glargine Sales Market Share in Value by Application in 2021
Table 69. Middle East and Africa Insulin Glargine Sales by Application (2017-2022) (M mL)
Table 70. Middle East and Africa Insulin Glargine Sales by Application (2017-2022) & (US$ Million)
Table 71. Middle East and Africa Insulin Glargine Sales Market Share in Value by Application in 2021
Table 72. North America Insulin Glargine Sales by Country (2017-2022) & (M mL)
Table 73. North America Insulin Glargine Sales Market Share in Volume by Country (2017-2022)
Table 74. North America Insulin Glargine Sales by Country (2017-2022) & (US$ Million)
Table 75. North America Insulin Glargine Sales Market Share in Value by Country (2017-2022)
Table 76. North America Insulin Glargine Sales by Country (2023-2028) & (M mL)
Table 77. North America Insulin Glargine Sales Market Share in Volume by Country (2023-2028)
Table 78. North America Insulin Glargine Sales by Country (2023-2028) & (US$ Million)
Table 79. North America Insulin Glargine Sales Market Share in Value by Country (2023-2028)
Table 80. Europe Insulin Glargine Sales by Country (2017-2022) & (M mL)
Table 81. Europe Insulin Glargine Sales Market Share in Volume by Country (2017-2022)
Table 82. Europe Insulin Glargine Sales by Country (2017-2022) & (US$ Million)
Table 83. Europe Insulin Glargine Sales Market Share in Value by Country (2017-2022)
Table 84. Europe Insulin Glargine Sales by Country (2023-2028) & (M mL)
Table 85. Europe Insulin Glargine Sales Market Share in Volume by Country (2023-2028)
Table 86. Europe Insulin Glargine Sales by Country (2023-2028) & (US$ Million)
Table 87. Europe Insulin Glargine Sales Market Share in Value by Country (2023-2028)
Table 88. Asia-Pacific Insulin Glargine Sales by Region (2017-2022) & (M mL)
Table 89. Asia-Pacific Insulin Glargine Sales Market Share in Volume by Region (2017-2022)
Table 90. Asia-Pacific Insulin Glargine Sales by Region (2017-2022) & (US$ Million)
Table 91. Asia-Pacific Insulin Glargine Sales Market Share in Value by Region (2017-2022)
Table 92. Asia-Pacific Insulin Glargine Sales by Region (2023-2028) & (M mL)
Table 93. Asia-Pacific Insulin Glargine Sales Market Share in Volume by Region (2023-2028)
Table 94. Asia-Pacific Insulin Glargine Sales by Region (2023-2028) & (US$ Million)
Table 95. Asia-Pacific Insulin Glargine Sales Market Share in Value by Region (2023-2028)
Table 96. Latin America Insulin Glargine Sales by Country (2017-2022) & (M mL)
Table 97. Latin America Insulin Glargine Sales Market Share in Volume by Country (2017-2022)
Table 98. Latin America Insulin Glargine Sales by Country (2017-2022) & (US$ Million)
Table 99. Latin America Insulin Glargine Sales Market Share in Value by Country (2017-2022)
Table 100. Latin America Insulin Glargine Sales by Country (2023-2028) & (M mL)
Table 101. Latin America Insulin Glargine Sales Market Share in Volume by Country (2023-2028)
Table 102. Latin America Insulin Glargine Sales by Country (2023-2028) & (US$ Million)
Table 103. Latin America Insulin Glargine Sales Market Share in Value by Country (2023-2028)
Table 104. Middle East and Africa Insulin Glargine Sales by Country (2017-2022) & (M mL)
Table 105. Middle East and Africa Insulin Glargine Sales Market Share in Volume by Country (2017-2022)
Table 106. Middle East and Africa Insulin Glargine Sales by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Insulin Glargine Sales Market Share in Value by Country (2017-2022)
Table 108. Middle East and Africa Insulin Glargine Sales by Country (2023-2028) & (M mL)
Table 109. Middle East and Africa Insulin Glargine Sales Market Share in Volume by Country (2023-2028)
Table 110. Middle East and Africa Insulin Glargine Sales by Country (2023-2028) & (US$ Million)
Table 111. Middle East and Africa Insulin Glargine Sales Market Share in Value by Country (2023-2028)
Table 112. Sanofi Corporation Information
Table 113. Sanofi Introduction and Business Overview
Table 114. Sanofi Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2017-2022)
Table 115. Sanofi Insulin Glargine Product
Table 116. Sanofi Recent Development
Table 117. Eli Lilly Corporation Information
Table 118. Eli Lilly Introduction and Business Overview
Table 119. Eli Lilly Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2017-2022)
Table 120. Eli Lilly Insulin Glargine Product
Table 121. Eli Lilly Recent Development
Table 122. Viatris Corporation Information
Table 123. Viatris Introduction and Business Overview
Table 124. Viatris Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2017-2022)
Table 125. Viatris Insulin Glargine Product
Table 126. Viatris Recent Development
Table 127. Gan&Lee Pharmaceuticals Corporation Information
Table 128. Gan&Lee Pharmaceuticals Introduction and Business Overview
Table 129. Gan&Lee Pharmaceuticals Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2017-2022)
Table 130. Gan&Lee Pharmaceuticals Insulin Glargine Product
Table 131. Gan&Lee Pharmaceuticals Recent Development
Table 132. Tonghua Dongbao Pharmaceutical Corporation Information
Table 133. Tonghua Dongbao Pharmaceutical Introduction and Business Overview
Table 134. Tonghua Dongbao Pharmaceutical Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2017-2022)
Table 135. Tonghua Dongbao Pharmaceutical Insulin Glargine Product
Table 136. Tonghua Dongbao Pharmaceutical Recent Development
Table 137. United Laboratories International Corporation Information
Table 138. United Laboratories International Introduction and Business Overview
Table 139. United Laboratories International Insulin Glargine Sales (M mL), Revenue (Million USD), Price (USD/mL) and Gross Margin (2017-2022)
Table 140. United Laboratories International Insulin Glargine Product
Table 141. United Laboratories International Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Insulin Glargine Market Trends
Table 145. Insulin Glargine Market Drivers
Table 146. Insulin Glargine Market Challenges
Table 147. Insulin Glargine Market Restraints
Table 148. Insulin Glargine Distributors List
Table 149. Insulin Glargine Downstream Customers
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Glargine Product Picture
Figure 2. Global Insulin Glargine Market Size, 2017 VS 2021 VS 2028 (US$ Million)
Figure 3. Global Insulin Glargine Market Size Status and Outlook (2017-2028) & (US$ Million)
Figure 4. Global Insulin Glargine Sales Status and Outlook (2017-2028) & (M mL)
Figure 5. Product Picture of Prefilled Injection
Figure 6. Global Prefilled Injection Sales YoY Growth (2017-2028) & (M mL)
Figure 7. Product Picture of Non-Prefilled Injection
Figure 8. Global Non-Prefilled Injection Sales YoY Growth (2017-2028) & (M mL)
Figure 9. Global Insulin Glargine Sales by Type (2017-2028) & (US$ Million)
Figure 10. Global Insulin Glargine Sales Market Share in Volume by Type (2017-2022)
Figure 11. Global Insulin Glargine Sales Market Share in Value by Type (2017-2022)
Figure 12. Global Insulin Glargine Sales Market Share in Volume by Type (2023-2028)
Figure 13. Global Insulin Glargine Sales Market Share in Value by Type (2023-2028)
Figure 14. North America Insulin Glargine Sales Market Share in Volume by Type in 2021
Figure 15. North America Insulin Glargine Sales Market Share in Value by Type in 2021
Figure 16. Europe Insulin Glargine Sales Market Share in Volume by Type in 2021
Figure 17. Europe Insulin Glargine Sales Market Share in Value by Type in 2021
Figure 18. Asia-Pacific Insulin Glargine Sales Market Share in Volume by Type in 2021
Figure 19. Asia-Pacific Insulin Glargine Sales Market Share in Value by Type in 2021
Figure 20. Latin America Insulin Glargine Sales Market Share in Volume by Type in 2021
Figure 21. Latin America Insulin Glargine Sales Market Share in Value by Type in 2021
Figure 22. Middle East and Africa Insulin Glargine Sales Market Share in Volume by Type in 2021
Figure 23. Middle East and Africa Insulin Glargine Sales Market Share in Value by Type in 2021
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Glargine Sales in 2021
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Glargine Revenue in 2021
Figure 26. Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 27. Product Picture of Type 1 Diabetes Treatment
Figure 28. Global Type 1 Diabetes Treatment Sales YoY Growth (2017-2028) & (M mL)
Figure 29. Product Picture of Type 2 Diabetes Treatment
Figure 30. Global Type 2 Diabetes Treatment Sales YoY Growth (2017-2028) & (M mL)
Figure 31. Global Insulin Glargine Sales by Application (2017-2028) & (US$ Million)
Figure 32. Global Insulin Glargine Sales Market Share by Application in 2021 & 2028
Figure 33. North America Insulin Glargine Sales Market Share in Volume by Application in 2021
Figure 34. Latin America Insulin Glargine Sales Market Share in Value by Application in 2021
Figure 35. Middle East and Africa Insulin Glargine Sales Market Share in Value by Application in 2021
Figure 36. Key Raw Materials Price
Figure 37. Insulin Glargine Manufacturing Cost Structure
Figure 38. Insulin Glargine Industrial Chain Analysis
Figure 39. Channels of Distribution
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs